In a trial of men with suspected prostate cancer, biparametric MRI, which excludes the gadolinium contrast sequence, was noninferior to multiparametric MRI for detecting clinically significant cases. 🧵 ja.ma/4nhCVqy

⚠️Not all men who need a prostate mpMRI get one 💡Could a shorter, cheaper, less invasive bpMRI work just as well? 🔥 PRIME Trial out in JAMA 🏆 Lvl 1 evidence that bpMRI non-inferior to mpMRI for PCa detection ⏱️ to improve global access 🔗jamanetwork.com/journals/jama/…

💡 How can we make prostate MRI available to all men who need it? 👇

🆕 Great to see #PRIME published - an effective and efficient trial to determine a new standard of practice 👏 What you won’t see published is the amount of hard work carried out behind the scenes to deliver this work Veeru Kasi Alexander Ng Dr Aqua Asif Read 👇

UCL-led research has found that a two-part MRI scan is just as effective as existing methods for diagnosing prostate cancer, whilst reducing time and cost. The findings are likely to lead to changes in clinical practice, making MRI accessible to more men. bit.ly/3Ih9bva

Bye bye gadolinium!! Prostate MRI just got easier. Hot off the press GU Cast on the PRIME trial Veeru Kasi COMPASS Research Group · UCL 🧭 Declan Murphy Renu Eapen JAMA Network youtu.be/5pZ27Iln7pg?si…

As of now, I am only ordering bpMRI for early detection of prostate cancer. And for AS patients if DCE added nothing on initial MRI (which is likely everybody). This is a good thing well done PRIME team. Saves time, money, plus deals with concerns about “gadolinium brain”.

BURST is honoured to collaborate with the NIHR-HTA BURST-ELIPSE Randomised Control Trial, a pivotal study shaping the future in surgical management of radical prostatectomy 👩‍⚕️👨‍⚕️

The OncoAlert WEEKLY RoundUp 🚨 Covering the TOP of the week Sept 12-18, 2025 REGISTER at OncoAlert360.com OR oncoalert.m-pages.com/nhMpwe/oncoale… Discussing: 🔹 PRIME Diagnostic Trial (JAMA): Biparametric MRI is noninferior to multiparametric MRI for #ProstateCancer 🔹

🚨Join our highly rated world class UCL VIRTUAL 2 day MRI Masterclass Nov 21-22 2025🚨 For urologists, radiologists, nurses, scientists anywhere in the 🌎 who want hands on experience in using prostate MRI 4 diagnosis & treatment #UroSoMe Book NOW ucl.ac.uk/short-courses/… 1/n

We have a fully funded 3 yr PhD post UCL, deadline 12th Nov. Research is on optimising prostate cancer diagnosis using imaging (e.g MRI, PET, AI). Join our world-class team with proven track-record 4 changing practice. ucl.ac.uk/work-at-ucl/se… BURST Urology The British Society of Urogenital Radiology European Society of Residents in Urology

Excited to partner with ELIPSE to advance research that will improve care & outcomes for prostate cancer patients in the UK and worldwide. 🌎

😀JAMA #PRIME trial presented this AM @ Uro-Oncology Grand Rounds ✅Lvl 1 evidence: shorter, cheaper, less-invasive bpMRI non-inferior to mpMRI for csPCa detection 🔥Top 0.03% (#9310) of 29.4M research outputs tracked by Altmetric 👉Full-text jamanetwork.com/journals/jama/…

🖥️ At today’s #UroOnc Grand Round, our Veeru Kasi presented #PRIME ⭐ Level-1 evidence: bpMRI (no contrast) = non-inferior to mpMRI for #ProstateCancer detection, with no rise in biopsies Great MDT discussion 👏 Read in JAMA 👇 jamanetwork.com/journals/jama/… #UroSoMe

An incredibly insightful session by Veeru Kasi on game changing urology research! Check out the post 👇

🎗️Thank you to the Mid-Sussex #ProstateCancer Support Group for inviting us to share our research 🤩 📄 Alexander Ng had the opportunity to discuss our work - #PRIME trial published in JAMA, and a #GLIMPSE into the importance of #quality published in Radiology

Immediately practice changing says Declan Murphy

📢 Meet some of our new ELIPSE–BURST Associate PIs! Interested in joining the network? 👩‍⚕️👨‍⚕️ Contact @BURSTUrology to find out more!

The UCL #ProstateMRI Masterclass 2025 is done! 2 days, 4 interactive MRI breakouts, many practical sessions, MDT cases & a seriously engaged global audience Huge thanks to our speakers, breakout supervisors, sponsors, organising team and every delegate who joined us💙 #UroSoMe

🔥TUF X BURST: X-Factor returns for #BAUS26 - this time bigger and better! Got a QIP, audit or innovation idea? Submit it for a chance to have it refined, present at BAUS 26 and a shot at a share of £1,000! ⌛Deadline: 1st Feb 2026 🔗Link: forms.gle/NpC5ayznq5TeaR… #UROSoMe